Abstract
Lichen planus (LP) is a chronic mucocutaneous autoimmune inflammatory disorder of the stratified squamous epitheliumthat mostly affects middle-aged adults. No significant differences in the incidence for LP are noticed between male and femalepatients. Squamous cell carcinoma antigen (SCCA) is known as a tumor biomarker for various squamous cell tumors. It was firstidentified in the uterine cervix by Kato and Torigoe. Total SCCA comprises nearly identical proteins. Both SCCAI and II belongto the ovalbumin-serpin proteinase inhibitor family. The aim of this work was to assess the serum levels of SCCAII in patientswith LP and compare it to its level in normal group. This was a case-control study conducted over a period of six months fromSeptember 2018 to march 2019 included 100 participants, 80 patients suffering from LP. In addition to 20 apparently healthy.Patients were selected from the outpatient clinic of Dermatology and Andrology Department of Benha University Hospitals andKafr Shokr central hospital. We found that Serum levels of SCCAII were significantly higher in patients with LP compared tohealthy control subjects. In conclusion, significant elevation of SSCCAII is associated with LP. Serum SCCAII may become anovel and useful biomarker for evaluating disease activity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
